Rapid diagnostic test for simultaneous detection of Influenza A and B viruses. Point-of-care testing for respiratory pathogen identification.
Manufactured by
Access Bio, Inc.
Somerset NJ, United States
BECAUSE ACCESS IS EVERYTHING Even the most sophisticated, cutting-edge medical diagnostics aren't of value unless we can get them to those who need them most At Access Bio, we believe every life is precious, and every human on earth deserves the opportunity to live a healthy life, free from the threat of infectious diseases. Access Bio is dedicated to the prevention and early diagnosis of infectious diseases through research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products Based on the greatest needs and the potential to do the most good, we work with partners across the world, including the Bill and Melinda Gates Foundation, the World Health Organization, UNICEF, and many others to ensure that life-saving diagnostics reach underserved populations globally.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Applied Biocode, Inc.
United States · 2 relevant products
ACON Laboratories, Inc.
United States · 1 relevant product
CALTH Inc.
South Korea · 3 relevant products
68 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 108 closest product alternatives
Applied Biocode, Inc. · United States
A clinical diagnostic assay for simultaneous detection of SARS-CoV-2 and influenza pathogens. This multiplex testing product incorporates Applied Biocode's Barcoded Magnetic Bead (BMB) technology for comprehensive respiratory pathogen identification.
Applied Biocode, Inc. · United States
Multiplex molecular diagnostic assay for simultaneous detection of SARS-CoV-2, Influenza A, and Influenza B. Enables comprehensive respiratory pathogen screening in single test format.
ACON Laboratories, Inc. · United States
A multiplex lateral flow immunoassay for simultaneous detection of SARS-CoV-2, influenza A, and influenza B. FDA-cleared for home-based testing with extended shelf-life stability.
105 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products